{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:14:14Z","timestamp":1789823654211,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jpeds.2012.02.048","type":"journal-article","created":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T08:37:27Z","timestamp":1333701447000},"page":"506-512.e1","source":"Crossref","is-referenced-by-count":107,"title":["Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin\u2013Resistant Kawasaki Disease"],"prefix":"10.1016","volume":"161","author":[{"given":"Adriana H.","family":"Tremoulet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Pancoast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Onouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Tamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guliz","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2012.02.048_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2012.02.048_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/323155","article-title":"CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease","volume":"184","author":"Brown","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2012.02.048_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/08916930903405891","article-title":"Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease","volume":"43","author":"Franco","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jpeds.2012.02.048_bib6","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.4049\/jimmunol.0901395","article-title":"Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease","volume":"183","author":"Schulte","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yexmp.2007.01.007","article-title":"Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease","volume":"83","author":"Yilmaz","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/intimm\/dxg007","article-title":"Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease","volume":"15","author":"Duong","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1546-0096-9-30","article-title":"Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease","volume":"9","author":"Takahashi","year":"2011","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib10","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/hmg\/ddq176","article-title":"Common variants in CASP3 confer susceptibility to Kawasaki disease","volume":"19","author":"Onouchi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpeds.2012.02.048_bib11","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease","author":"Onouchi","year":"2011","journal-title":"Pharmacogenom J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/jhg.2010.154","article-title":"CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children","volume":"56","author":"Kuo","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jpeds.2012.02.048_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.inf.0000125893.66941.e0","article-title":"Refractory Kawasaki disease","volume":"23","author":"Freeman","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ng.981","article-title":"Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease","volume":"43","author":"Khor","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jpeds.2012.02.048_bib15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/ng.482","article-title":"A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population","volume":"41","author":"Asano","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jpeds.2012.02.048_bib16","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2012.02.048_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/INF.0b013e318220c3cf","article-title":"Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin","volume":"30","author":"Suzuki","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/039463201002300421","article-title":"Bioavailability of Sandimmun\u00ae versus Sandimmun Neoral\u00ae: a meta-analysis of published studies","volume":"23","author":"Colombo","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib19","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0041-1345(98)00505-3","article-title":"Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation","volume":"30","author":"Gusmano","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2012.02.048_bib20","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2012.02.048_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00246-009-9599-7","article-title":"Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease","volume":"31","author":"Manlhiot","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib22","doi-asserted-by":"crossref","first-page":"e1000319","DOI":"10.1371\/journal.pgen.1000319","article-title":"A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease","volume":"5","author":"Burgner","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jpeds.2012.02.048_bib23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2012.02.048_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2012.02.048_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00006454-200106000-00022","article-title":"Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy","volume":"20","author":"Raman","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib26","first-page":"349","article-title":"Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin","volume":"66","author":"Mori","year":"2008","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.jpeds.2012.02.048_bib27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1542\/peds.112.4.986","article-title":"Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect","volume":"112","author":"Kuijpers","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2012.02.048_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3476(96)70447-X","article-title":"Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids","volume":"128","author":"Wright","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2012.02.048_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/INF.0b013e3181950b64","article-title":"Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease","volume":"28","author":"Kobayashi","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2012.02.048_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(84)80097-9","article-title":"Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease","volume":"105","author":"Koren","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2012.02.048_bib31","first-page":"415","article-title":"Salicylates in Kawasaki disease: a review of clinical pharmacokinetics and efficacy","volume":"250","author":"Koren","year":"1987","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jpeds.2012.02.048_bib32","unstructured":"Lexi-Comp Online. Pediatric & Neonatal Lexi-Drugs Online. Available at http:\/\/online.lexi.com\/crlsql\/servlet\/crlonline. Accessed January 3, 2012."},{"key":"10.1016\/j.jpeds.2012.02.048_bib33","doi-asserted-by":"crossref","first-page":"420S","DOI":"10.1016\/j.transproceed.2004.01.054","article-title":"Evolution of the therapeutic drug monitoring of cyclosporine","volume":"36","author":"Citterio","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2012.02.048_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1399-3046.2008.00968.x","article-title":"Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients: the trough level is not enough","volume":"13","author":"Schrauder","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpeds.2012.02.048_bib35","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/00007890-199812270-00009","article-title":"Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients","volume":"66","author":"Cantarovich","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jpeds.2012.02.048_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FTD.0b013e318210e6d0","article-title":"Monitoring of nuclear factor of activated T-cell\u2013regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine A","volume":"33","author":"Herden","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jpeds.2012.02.048_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng.2007.59","article-title":"ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms","volume":"40","author":"Onouchi","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jpeds.2012.02.048_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jpeds.2012.02.048_bib39","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1074\/jbc.M511759200","article-title":"Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3","volume":"281","author":"Wu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpeds.2012.02.048_bib40","doi-asserted-by":"crossref","unstructured":"1000 Genome Consortium. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.","DOI":"10.1038\/nature09534"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234761200251X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234761200251X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T05:55:21Z","timestamp":1641966921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002234761200251X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S002234761200251X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2012.02.048","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}